Oligonucleotide Synthesis Market Expected to Reach USD 3,697 Million By 2026, Globally: Zion Market Research

According to the report, the global oligonucleotide synthesis market was valued at approximately USD 1,508 million in 2017 and is expected to generate around USD 3,697 million by 2026, at a CAGR of around 10.6% between 2019 and 2026.

New York, NY, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Oligonucleotide Synthesis Market by Offering (Equipment, Reagents and Consumables, and Synthesized Oligonucleotides [Product and Services), by Application (Research, Therapeutics, and Diagnostics), and by End-User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2026”. According to the report, the global oligonucleotide synthesis market was valued at approximately USD 1,508 million in 2017 and is expected to generate around USD 3,697 million by 2026, at a CAGR of around 10.6% between 2019 and 2026.

Small fragments of nucleic acids that are synthesized via enzyme chemistry and genetic engineering are known as oligonucleotides. These are mainly used in laboratories for diagnostics, therapeutics, and in academic and industrial research. Oligonucleotides are also used for initial screening of target validation and drug production. The oligonucleotides synthesis market is likely to benefit from the constant growth of gene editing and genomics markets, as there are a large number of advancements related to genetic tools for simplifying the synthesis of oligonucleotide process.

Browse through 72 Tables & 27 Figures spread over 110 Pages and in-depth TOC on “Global Oligonucleotide Synthesis Market: Type, Size, Share, Industry Offerings, Analysis Report and Forecast, 2018—2026”.

Request Free Sample Report of Global Oligonucleotide Synthesis Market Report @ https://www.zionmarketresearch.com/sample/oligonucleotide-synthesis-market

The global market for oligonucleotide synthesis is segmented on the basis of offering, application, and end-user. By offering, the oligonucleotide synthesis market is segmented into equipment, reagents and consumables, and synthesized oligonucleotides. The synthesized oligonucleotides market is further divided into product and services. The products segment includes large-scale synthesis oligonucleotides, probes, primers, linkers and adaptors, intermediate-scale synthesis oligonucleotides, and others. The services segment includes custom/specialty oligonucleotides (modified and non-modified oligonucleotides) and pre-designed oligonucleotides. The growing applications of ready-to-use synthesized oligonucleotides in therapeutics and a large number of manufacturers offering various customizations is likely to drive the synthesized oligonucleotides segment in the years ahead.

By application, this global market includes research, therapeutics, and diagnostics. The research segment includes polymerase chain reaction, qPCR, next-generation sequencing, and others. The therapeutics segment includes antisense oligonucleotides, RNAi, nucleic acid aptamers, and immunotherapy applications. There is a rising demand for oligonucleotides for diagnostic purposes due to its growing demand for molecular diagnosis of inherited disorders. By end-user, the market includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic research institutes, and others. Pharmaceutical and biotechnology companies are more focused on finding alternative approaches to disease treatment, thereby, making significant use of oligonucleotides. This, in turn, is offering an effective mode of action for treatment of various indications at a comparatively low development cost.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/oligonucleotide-synthesis-market

By region, the global oligonucleotide synthesis market includes North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America is anticipated to dominate the market for oligonucleotide synthesis and hold a major share, i.e., 31.1%, of the oligonucleotide synthesis market over the forecast timeline. This regional dominance can be attributed to the growing prevalence of genetic diseases and the subsequent demand for new and advanced drugs, the rising R&D expenditure by private entities and governments. Furthermore, major advances in pharmaceutical and biological sciences and the introduction of more effective drugs with more curative and preventive treatment effects are aimed at enhancing the quality of human life. The rise in the incidences of chronic illnesses due to increasing aging population has further impelled advancements in drugs aimed in oncology and gene therapy to prevent and treat chronic illnesses. Considerable push to develop advanced and new technologies to build new molecules of oligonucleotides for therapeutic use is further predicted to contribute toward the North American oligonucleotide synthesis market in the future.

The Asia Pacific region is projected to showcase the highest rate of growth in the oligonucleotide synthesis market in the future. Asian countries are considered to be the fastest adopters of array technology, sequencing, and PCR products due to speedy progress in the field of genomic studies. China and India are considered as the most attractive markets with respect to growth opportunities in this market. Moreover, life science-related research programs and changing economic scenario along with huge investments in healthcare and genetics sectors are likely to drive the growth of the Asia Pacific oligonucleotide synthesis market in the years ahead.

Browse the full “Oligonucleotide Synthesis Market by Offering (Equipment, Reagents and Consumables, and Synthesized Oligonucleotides [Product and Services), by Application (Research, Therapeutics, and Diagnostics), and by End-User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2026” Report at https://www.zionmarketresearch.com/report/oligonucleotide-synthesis-market

The Middle Eastern and African and Latin American regions are likely to hold the most potential in this global market, owing to the growing demand for customized oligonucleotides and the increasing need for better health outcomes, improving healthcare infrastructure, and the rising prevalence of infectious and chronic diseases in these regions.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/oligonucleotide-synthesis-market

Some leading players of the global oligonucleotide synthesis market include ATD Bio Ltd., BianoScience GmbH, BioSpring GmbH, Bioneer Corporation, Bio-Synthesis, Inc., Creative Biogene, Dalton Pharma Services, Eurofins Genomics, GE, GeneDesign, Inc., GenScript, IBA GmbH, Integrated DNA Technologies, Inc., Kaneka Eurogentec S.A., LGC Biosearch Technologies, Merck KGaA, Microsynth AG, Syngene, Thermo Fisher Scientific, Inc., TriLink BioTechnologies, LLC, and Twist Bioscience.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/485

This report segments the global oligonucleotide synthesis market into:

Global Oligonucleotide Synthesis Market: Offering Analysis

  • Equipment
  • Reagents and Consumables
  • Synthesized Oligonucleotides
    • By Product
      • Primers
      • Probes
      • Large-Scale Synthesis Oligonucleotides
      • Intermediate-Scale Synthesis Oligonucleotides
      • Linkers and Adaptors
      • Others
    • By Service
      • Custom/Specialty Oligonucleotides
        • Modified
        • Non-Modified
      • Pre-Designed Oligonucleotides

Global Oligonucleotide Synthesis Market: Application Analysis

  • Research
    • Polymerase Chain Reaction
    • qPCR
    • Next Generation Sequencing
    • Others
  • Therapeutics
    • Antisense Oligonucleotides
    • RNAi
    • Nucleic Acid Aptamers
    • Immunotherapy Applications
  • Diagnostics

Global Oligonucleotide Synthesis Market: End-User Analysis

  • Academic Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

Global Oligonucleotide Synthesis Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Browse More Related Category Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://usindustrynews.com | http://europeindustrynews.com | http://zmrresearchnews.us | http://zmrmarketjournal.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com

Ads